Therefore, this study posits that Srxn1 exerts anti‐inflammatory and antioxidant effects by targeting the TLR4/NF‐κB signalling pathway, thereby improving pathological myocardial remodelling after HF. The gene discussed is TLR4; the disease is hydrops fetalis.